TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Panadact Life Science AB
Closing information (x1000 NOK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
1,274
|
1,001
|
1,168 |
| Financial expenses |
1
|
1
|
1 |
| Earnings before taxes |
487
|
599
|
172 |
| EBITDA |
300
|
-62
|
163 |
| Total assets |
1,951
|
1,650
|
1,044 |
| Current assets |
1,375
|
1,173
|
562 |
| Current liabilities |
993
|
621
|
280 |
| Equity capital |
612
|
809
|
643 |
| - share capital |
47
|
49
|
52 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
31.4%
|
49.0%
|
61.6% |
| Turnover per employee |
1,274
|
1,001
|
1,168 |
| Profit as a percentage of turnover |
38.2%
|
59.8%
|
14.7% |
| Return on assets (ROA) |
25.0%
|
36.4%
|
16.6% |
| Current ratio |
138.5%
|
188.9%
|
200.7% |
| Return on equity (ROE) |
79.6%
|
74.0%
|
26.7% |
| Change turnover |
304
|
-87
|
111 |
| Change turnover % |
31%
|
-8%
|
11% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.